Weller, Johannes http://orcid.org/0000-0001-5818-5392
Zeyen, Thomas
Schäfer, Niklas
Schaub, Christina
Potthoff, Anna-Laura http://orcid.org/0000-0002-5710-6557
Steinbach, Joachim P.
Hau, Peter http://orcid.org/0000-0003-3894-5053
Seidel, Clemens
Goldbrunner, Roland
Tabatabai, Ghazaleh
Vatter, Hartmut
Tzaridis, Theophilos
Schneider, Matthias http://orcid.org/0000-0002-6025-7479
Herrlinger, Ulrich
Funding for this research was provided by:
Universitätsklinikum Bonn
Article History
Received: 1 September 2023
Accepted: 26 September 2023
First Online: 3 October 2023
Declarations
:
: The trial was performed in line with the principles of the Declaration of Helsinki and the Guidelines for Good Clinical Practice. The ethics committees of all participating centers approved the trial.
: Written informed consent was obtained from all individual participants.
: JPS has received lecture, travel or advisory board honoraria from Boehringer Ingelheim, Med-Update, Roche, Novocure and Seagen. PH has received lecture and/or advisory board honoraria from Lilly, Medac, Novocure and Seagen. CSe has received speaker and/oradvisory board honoraria from Abbvie, Bristol-Myers Squibb, HRA Pharma, Medac, Novocure, Roche and Seagen. UH has received lecture and/or advisory board honoraria from Medac and Bayer. The other authors declare that they have no financial interests.